"Disease Management" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A broad approach to appropriate coordination of the entire disease treatment process that often involves shifting away from more expensive inpatient and acute care to areas such as preventive medicine, patient counseling and education, and outpatient care. This concept includes implications of appropriate versus inappropriate therapy on the overall cost and clinical outcome of a particular disease. (From Hosp Pharm 1995 Jul;30(7):596)
| Descriptor ID |
D019468
|
| MeSH Number(s) |
N04.590.607
|
| Concept/Terms |
Disease Management- Disease Management
- Disease Managements
- Management, Disease
- Managements, Disease
|
Below are MeSH descriptors whose meaning is more general than "Disease Management".
Below are MeSH descriptors whose meaning is more specific than "Disease Management".
This graph shows the total number of publications written about "Disease Management" by people in this website by year, and whether "Disease Management" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2004 | 1 | 1 | 2 |
| 2006 | 0 | 2 | 2 |
| 2007 | 1 | 5 | 6 |
| 2008 | 0 | 2 | 2 |
| 2009 | 0 | 2 | 2 |
| 2010 | 1 | 5 | 6 |
| 2011 | 5 | 5 | 10 |
| 2012 | 6 | 5 | 11 |
| 2013 | 11 | 9 | 20 |
| 2014 | 19 | 17 | 36 |
| 2015 | 27 | 18 | 45 |
| 2016 | 16 | 23 | 39 |
| 2017 | 20 | 28 | 48 |
| 2018 | 12 | 23 | 35 |
| 2019 | 8 | 25 | 33 |
| 2020 | 12 | 25 | 37 |
| 2021 | 3 | 20 | 23 |
| 2023 | 1 | 0 | 1 |
| 2024 | 0 | 17 | 17 |
| 2025 | 2 | 4 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Disease Management" by people in Profiles.
-
Peripheral T-cell lymphoma-NOS in children and adolescents: a?review from the Children's Oncology Group NHL Committee. Blood Adv. 2025 Mar 25; 9(6):1420-1431.
-
Navigating the Complexities of Common Variable Immunodeficiency Enteropathy: From Established Therapies to Emerging Interventions. Immunol Allergy Clin North Am. 2025 May; 45(2):267-285.
-
Multidisciplinary approach to treating complex immune dysregulation disorders: an adaptive model for institutional implementation. Front Immunol. 2025; 16:1519955.
-
Clinical management and therapeutic optimization of patients with heart failure with reduced ejection fraction and low blood pressure. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2025 Apr; 27(4):707-722.
-
The Comparative Epidemiology, Pathophysiology and Management of Cardiogenic Shock Associated With Acute Myocardial Infarction and Advanced Heart Failure. Can J Cardiol. 2025 Apr; 41(4):573-586.
-
Chronic myelomonocytic leukemia: molecular pathogenesis and therapeutic innovations. Haematologica. 2025 Jan 01; 110(1):22-36.
-
Promoting Prevention and Targeting Remission of Asthma: A EUFOREA Consensus Statement on Raising the Bar in Asthma Care. Chest. 2025 Apr; 167(4):956-974.
-
KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD. Am J Kidney Dis. 2025 Feb; 85(2):135-176.
-
What is in a name: defining pediatric refractory ITP. Blood Adv. 2024 10 08; 8(19):5112-5117.
-
Leptomeningeal metastases from solid tumors: A Society for Neuro-Oncology and American Society of Clinical Oncology consensus review on clinical management and future directions. Neuro Oncol. 2024 Oct 03; 26(10):1781-1804.